Edwards Lifesciences Takes Over #37 Spot From Vertex Pharmaceuticals
April 23, 2018 at 12:00 PM EDT
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp (EW) has taken over the #37 spot from Vertex Pharmaceuticals, Inc. (VRTX), according to ETF Channel..